The Power List 2022 focuses on the top 10 VIPs in three key categories of medicine making
| 9 min read
The International Society for Cell & Gene Therapy convened in person for the first time in two years. We spoke to an attendee for an insight
| 7 min read
In our third C+G Champions installment, we ask industry leaders in the cell and gene field about accessibility for the many
The Medicine Maker and NIBRT present the Biopharma Trends Leaders’ Report 2022.
by Charles River
| 3 min read
Cell and gene therapy manufacturers need to make better plasmid design decisions with commercialization in mind.
| 4 min read
What role will CAR-Tregs play in the growing advanced therapy landscape?
Looking for a snapshot of what’s going on in the advanced medicine space? Download our free eBook!
Celebrate the people, companies, and innovations had the biggest impact on pharma in the last year.
Viral vectors can enable innovative medical treatments, but only with a comprehensive formulation development plan
The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards
Viral vector manufacture has come a long way, but the story is far from over.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
The Grand Winner
How Data Sharing Can Upgrade AI for Pharma
Welcome to the CRISPR Powerhouse